Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-81
Closed -$2K 1021
2022
Q3
$2K Hold
81
﹤0.01% 1014
2022
Q2
$2K Buy
+81
New +$2.72K ﹤0.01% 953
2020
Q1
Sell
-88
Closed -$2K 177
2019
Q4
$2K Buy
+88
New +$1.95K ﹤0.01% 237

Other funds holding ADNT

Crewe Advisors's ADNT Position: Q4 2022 in Review

Crewe Advisors sold out of Adient (ADNT) in Q4 2022, closing a stake of 81 shares — an estimated $2K sold.

Crewe Advisors first reported a position in ADNT in Q4 2019 and held it in 3 quarters. The position peaked at $2K in Q3 2022. 273 funds tracked by Wall St. Rank hold ADNT as of Q4 2022.

  • Crewe Advisors reported no remaining Adient position as of Q4 2022 after selling out during the quarter.
  • Crewe Advisors sold 81 Adient shares in Q4 2022, an estimated $2K.
  • Crewe Advisors first reported a position in Adient in Q4 2019 and held it in 3 quarters.
  • Crewe Advisors's Adient position peaked at $2K in Q3 2022.
  • 273 funds tracked by Wall St. Rank held Adient as of Q4 2022.

Based on Crewe Advisors's 13F filing for Q4 2022, filed 8 Feb 2023.